MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD
62.52
+0.01 (+0.02%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close62.51
Open62.06
Bid0.00 x 0
Ask0.00 x 0
Day's Range62.01 - 62.54
52 Week Range52.83 - 66.41
Volume6,877,574
Avg. Volume9,856,355
Market Cap168.198B
Beta1.06
PE Ratio (TTM)108.54
EPS (TTM)0.58
Earnings DateJul 27, 2018
Forward Dividend & Yield1.92 (3.09%)
Ex-Dividend Date2018-06-14
1y Target Est69.44
Trade prices are not sourced from all markets
  • Stanley Black & Decker release earnings, State Street goes shopping, Starbucks opens 'signing store'
    Yahoo Financeyesterday

    Stanley Black & Decker release earnings, State Street goes shopping, Starbucks opens 'signing store'

    Stanley Black & Decker, Microsoft, State Street, Merck and Starbucks are the companies to watch.

  • Merck touts a 60% price cut, but the drug is outdated and on the way out
    MarketWatch18 hours ago

    Merck touts a 60% price cut, but the drug is outdated and on the way out

    Drugmakers have been lining up to tout new drug price policies lately, from deferring increases to freezing drug prices. Merck & Co. Inc. went a step further on Thursday, announcing a cap on average increases and cuts to some drug prices. The largest percentage cut announced was a 60% price reduction for its Zepatier treatment for hepatitis C.

  • Reuters20 hours ago

    Swiss, German drugmakers join U.S. price freeze

    European drugmakers Roche , Bayer and Merck KGaA became the latest companies to freeze prices in the United States for the rest of 2018 following criticism by President Donald Trump over the cost of medicine. Roche did boost U.S. prices for nine key drugs by an average of 3 percent on July 1, but said it would hold off additional increases as discussions with the Trump administration continue over a longer-term solution to containing healthcare costs.

  • Benzinga22 hours ago

    Merck Announces Plans To Cut Drug Prices

    Last week, Pfizer Inc. (NYSE: PFE) announced plans to restructure the company and plans to deter price increases for as long as possible, assuming that Trump makes some changes. Merck announced Thursday that it will lower the price of several medications while also limiting future price increases. The price of several medications will drop by 10 percent, including Prinivil, Remeron and Trusopt, according to Merck.

  • Roche Hiked Cancer-Drug Prices Before Pledge to Keep Them Flat
    Bloomberg23 hours ago

    Roche Hiked Cancer-Drug Prices Before Pledge to Keep Them Flat

    Like a growing number of its peers, Roche Holding AG pledged this week not to raise drug prices for the rest of the year. Roche gave the U.S. government its no-price-rises promise on July 11, the company said in a statement Friday. The health system also needs to focus on “long-term, system-wide solutions that lower costs,” Roche said.

  • Reuters23 hours ago

    Swiss, German drugmakers join U.S. price freeze

    European drugmakers Roche (ROG.S), Bayer (BAYGn.DE) and Merck KGaA (MRCG.DE) became the latest companies to freeze prices in the United States following criticism by the Trump administration of the cost of medicine. Roche, Bayer and Merck KGaA all said on Friday they would not seek to lift prices this year in the world's biggest drug market, following Novartis (NOVN.S), Pfizer (PFE.N) and U.S. drugmaker Merck (MRK.N) which had already announced similar moves.

  • Merck to Cut Price of Few Drugs Amid Drug Pricing Controversy
    Zacksyesterday

    Merck to Cut Price of Few Drugs Amid Drug Pricing Controversy

    Merck (MRK) announces a 60% cut in U.S. list prices for its hepatitis C drug, Zepatier. It will also lower the list price of some other drugs by 10%.

  • Better Buy: Eli Lilly and Company vs. Merck & Co.
    Motley Foolyesterday

    Better Buy: Eli Lilly and Company vs. Merck & Co.

    Which stock wins in a one-on-one matchup between these two big drugmakers?

  • Motley Foolyesterday

    Eli Lilly Scores a Win in Diabetes

    A new study may give sales of one of its diabetes drugs a boost.

  • MARKETS: Honeywell stock pops after raising full year guidance
    Yahoo Finance Video23 hours ago

    MARKETS: Honeywell stock pops after raising full year guidance

    Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action after Honeywell reported second quarter adjusted earnings per share and revenue that beat Wall Street Expectations.

  • Merck reduced prices of small and insignificant drugs: An...
    CNBC Videos19 hours ago

    Merck reduced prices of small and insignificant drugs: An...

    Michael Yee, Jefferies managing director, sheds light on Merck reducing prices on several drugs following Pfizer and Novartis announcing they will freeze price increases for the rest of the year.